Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
FIG. 2 MP
Pera EM et al. (2024) |
Xla Wt + serpine2 MO
NF20 (in situ hybridization) |
|
||||||
Fig. 2 de
Alasaadi DN et al. (2024) |
Xla Wt + deflation
NF15 (in situ hybridization) |
|||||||
Fig. 3 g
Alasaadi DN et al. (2024) |
Xla Wt + dorso-lateral marginal zone transplant + deflation
NF18 (in situ hybridization) |
|
||||||
Fig. 3 f
Alasaadi DN et al. (2024) |
Xla Wt + dorso-lateral marginal zone transplant + inflation
NF16-17 (in situ hybridization) |
|
||||||
Fig. 6 j (r2c1)
Alasaadi DN et al. (2024) |
Xla Wt + Inflation
NF14 (in situ hybridization) |
|
||||||
Fig. 2 de
Alasaadi DN et al. (2024) |
Xla Wt + Inflation
NF15 (in situ hybridization) |
|||||||
xFig. 5 de
Alasaadi DN et al. (2024) |
Xla Wt + ouabain
NF15 (in situ hybridization) |
|
||||||
Fig. 4 de
Alasaadi DN et al. (2024) |
Xla Wt + wnt8a
NF16-17 (in situ hybridization) |
|
||||||
Fig. 4 de
Alasaadi DN et al. (2024) |
Xla Wt + wnt8a + yap1 MO
NF16-17 (in situ hybridization) |
|
||||||
Fig. 4 def
Alasaadi DN et al. (2024) |
Xla Wt + yap1 MO
NF16-17 (in situ hybridization) |
|